Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Dublin – page 28

443 clinical trials in Dublin, Ireland across 14 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dublin at a glance
443
clinical trials
  • Research sites14
Type of trial
Recruitment status
Quick filters

443 trials in Dublin

Open in trial search

Study of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Mavacamten
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Adenocarcinoma gastric+1

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Fragile X syndrome

Not recruiting

Study on Long-Term Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years
  • Substances:Cannabidiol
  • Sponsor:Harmony Biosciences Management Inc.

Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Myelofibrosis

Not recruiting

Study Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Busulfan
  • Sponsor:Celgene Corp.

Iron deficiency anaemia+1

Not recruiting

Study on Daily vs. Alternate Day Iron Supplements for Treating Iron Deficiency Anemia in Pregnant Women

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Iron
  • Sponsor:University College Dublin

Haemophilia

Not recruiting

Study of Long-term Safety and Efficacy of Fitusiran in Patients with Hemophilia A or B with or without Inhibitory Antibodies to Factor VIII or IX

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Fitusiran
  • Sponsor:Genzyme Corp.

Uveal melanoma+2

Not recruiting

Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Belzupacap Sarotalocan
  • Sponsor:Aura Biosciences Inc.

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Mantle cell lymphoma

Not recruiting

Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:BeOne Medicines AG

Study of Tremelimumab, Durvalumab, and Drug Combination for Patients with Advanced Liver Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:University College Dublin

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Dublin

What the registry says about research in the country

01 Oncology Research

Clinical trials investigating innovative treatments for various cancer types, including non-small cell lung cancer, diffuse large B-cell lymphoma, and multiple myeloma. Studies focus on evaluating novel therapeutic combinations and immunotherapy approaches.

  • Metastatic Breast Cancer Treatment
  • Prostate Cancer Therapies
  • Lymphoma Management

Research emphasizes improving patient outcomes through targeted therapies and combination treatments.

02 Infectious Disease Prevention

Studies examining preventive measures against infectious diseases, including HIV prevention and monkeypox vaccination. Research focuses on vaccine efficacy and prophylactic treatments.

  • Pre-exposure Prophylaxis
  • Vaccine Booster Studies
  • Immunogenicity Assessment

Trials aim to enhance protection against emerging infectious diseases through innovative approaches.

03 Chronic Disease Management

Investigations into treatments for chronic conditions, including Sjögren's Disease, Ulcerative Colitis, and Hereditary Angioedema. Studies evaluate both novel therapeutics and existing treatment optimization.

  • Autoimmune Disorders
  • Inflammatory Conditions
  • Metabolic Diseases

Research focuses on improving quality of life and disease management for patients with chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.